InvestorsHub Logo
Followers 3
Posts 1781
Boards Moderated 0
Alias Born 07/06/2004

Re: None

Tuesday, 05/19/2009 2:02:12 PM

Tuesday, May 19, 2009 2:02:12 PM

Post# of 1467
JAV...Two germane snippets from YMB

.....It is otherwise a useless message board....


>>I'm not saying there will be an immediate groundswell of use, but there clearly will be a niche for this drug- none of us know how much of a niche without a crystal ball and proper marketing by a big pharma. Remember, there is no other IV NSAID available- so any alternative with a better safety profile will find a niche.<<


>>they didn't even try to sell dyloject, sport..All they were trying to do was get the drug on the hospital formularies, which of course they did.. it wouldnt have mattered if JAV had a cure for cancer, some jackleg drug reps they pulled off the street couldn't sell it.

if Dyloject wasn't a great drug, Therabel wouldnt have partnered up with them.

There's a hedge fund that owns 4 million shares of JAV that spent 100k on independent US dyloject research before they loaded up. thats right, $100,000. and when it got at 50 cents, they bought 2.5 million additional shares. They only had 1.5 million before that.<<<

-------------

1/
Dyloject...2 ph 3's already reported..Safety trial results in July

Ereska....top line ph 3 results expected anytime

2/
New CEO as of March/08....CC ten days ago said No share dilution...Management also swapped $100K salary for stock options two weeks ago.. I believe it is bullish...$200 or $300K of salary vs. $18 million cash on hand...no debt

...We shall see...

do your dd